BEAM
Beam TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
BEAM vs peer average
90/100
BEAM vs. peer average (A vs. C)
Grade spread
A 1 · B 2 · C 1 · D 3 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
AMGN is the first available peer comparator.
Large-cap biopharma benchmark, but materially larger and diversified, making direct valuation comparison weak.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
BEAM
Beam Therapeutics
AMGN
Amgen
Grade
A
D
Momentum
25
72
Value
41
63
Sentiment
92
42
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs AMGN
BEAM / AMGN
Grade Position
Above peers
BEAM vs. peer average (A vs. C)
90/100
Momentum
25
AMGNValue
41
AMGNSentiment
92
BEAMRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs BEAM
AMGN is the first peer returned for this comparison set.